Dupixent

Bristol Myers backs out of Dupixent fight, axing allergy asset despite phase 3 win
Fierce Biotech
Fri, 02/7/25 - 11:11 am
Bristol Myers Squibb
Dupixent
cendakimab
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Fierce Pharma
Thu, 02/6/25 - 10:50 pm
Regeneron
Sanofi
Dupixent
legal
Regeneron Beats Quarterly Estimates on Eczema Drug Demand; Launches Dividend Program
US News and World Report
Tue, 02/4/25 - 09:25 am
Regeneron
Dupixent
earnings
stock buyback
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Clinical Trials Arena
Thu, 01/16/25 - 11:09 am
Sanofi
KT-474
Kymera Therapeutics
atopic dermatitis
Dupixent
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Benzinga
Fri, 11/15/24 - 11:15 am
Regeneron
Sanofi
Dupixent
FDA
chronic spontaneous urticaria
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Regeneron
Sanofi
Dupixent
COPD
FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Sanofi
Regeneron
Dupixent
COPD
China
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tue, 07/30/24 - 11:30 am
Sanofi
Regeneron
Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters
Thu, 07/25/24 - 11:26 am
Sanofi
Dupixent
earnings
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Sanofi reports positive data from Phase III EoE treatment trial
Clinical Trials Arena
Thu, 06/27/24 - 11:29 am
Sanofi
Dupixent
eosinophilic esophagitis
clinical trials
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
pharma advertising
DTC advertising
Dupixent
Regeneron
Sanofi
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
Dupixent recaptures top Rx, OTC pharma brand spot in April
Medical Marketing and Media
Wed, 05/8/24 - 11:03 pm
DTC advertising
Dupixent
Sanofi
Regeneron
Dupixent’s DU More campaign breathes life into asthma treatment space
Medical Marketing and Media
Mon, 04/29/24 - 09:53 am
Dupixent
DTC advertising
Sanofi
Regeneron
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis

Pages